Does prediabetes qualify for Mounjaro?

Mounjaro (tirzepatide) is primarily approved for the treatment of type 2 diabetes, not prediabetes. However, its use for prediabetes may depend on individual circumstances and healthcare provider recommendations.

• Prediabetes: A condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes (A1C: 5.7% to 6.4%).
• Mounjaro: A GLP-1 and GIP receptor agonist that helps improve blood sugar control and may aid in weight loss.

If you have prediabetes and are considering Mounjaro, consult your healthcare provider to discuss whether it’s appropriate for your specific situation.